Related Experiment Videos
Technical aspects of automatic micronucleus analysis in rodent bone marrow assays
1Sandoz Pharma Ltd, Basle, Switzerland.
Cell Biology and Toxicology
|December 1, 1994
Summary
Automated analysis of mouse bone marrow micronucleus tests using computerized imaging significantly speeds up genotoxicity evaluation for new pharmaceutical drugs.
Area of Science:
- Toxicology
- Genetics
- Pharmacology
Background:
- The mouse bone marrow micronucleus assay is a standard in vivo test for genotoxicity.
- It detects chromosomal damage or mitotic spindle apparatus damage induced by chemical agents.
- Accurate and efficient evaluation is crucial for pharmaceutical drug development.
Purpose of the Study:
- To review the current state-of-the-art in automated rodent micronucleus evaluation.
- To highlight the combination of computerized image analysis and cellulose column fractionation.
- To assess the efficiency and applicability of automated scoring in pharmaceutical testing.
Main Methods:
- Utilizing computerized image analysis for micronucleus scoring.
- Employing the cellulose column fractionation technique for high-quality slide preparation.
- Reviewing data from automated micronucleus analysis in pharmaceutical drug testing.
Main Results:
- Automated micronucleus scoring with the Leitz MIAC image analyzer is substantially faster than manual analysis.
- High-quality slides are achievable through cellulose column fractionation, removing nucleated cells.
- Automatic scoring can process up to 16 slides overnight.
- Successful application of automated analysis in pharmaceutical drug testing for over 3 years.
Conclusions:
- Automated rodent micronucleus evaluation offers significant speed advantages.
- The combination of advanced slide preparation and image analysis enhances genotoxicity testing efficiency.
- Automated micronucleus analysis is a validated and effective tool for pharmaceutical research.